Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (371-380 of 432) with videos related to

Pageof 44
Sort By:
Hepatology (Baltimore, Md.)|July 1, 1992
Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantationC V Paya, R H Wiesner, P E Hermans, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 20, 2002
Liver allograft iron accumulation in patients with and without pretransplantation hepatic hemosiderosisMonica B Parolin, Kenneth P Batts, Russell H Wiesner, et al.
Journal of Hypertension|August 31, 1999
Neural mechanisms in human obesity-related hypertensionM S Rumantir, M Vaz, G L Jennings, et al.
Mayo Clinic Proceedings|February 1, 1989
Evaluation of preoperative hematology-coagulation screening in liver transplantationD M Ritter, C A Owen, E J Bowie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantationsR C Walker, C V Paya, W F Marshall, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantationW R Kim, J J Poterucha, R A Jorgensen, et al.
The New England Journal of Medicine|June 29, 1989
Efficacy of liver transplantation in patients with primary biliary cirrhosisB H Markus, E R Dickson, P M Grambsch, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2014
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trialS K Asrani, R H Wiesner, J F Trotter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 11, 2000
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic studyR B Guerrero, K P Batts, L J Burgart, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueW J Sandborn, G M Lawson, T J Cody, et al.
Pageof 44

Showing results (371-380 of 432) with videos related to

Sort By:
Pageof 44
Hepatology (Baltimore, Md.)|July 1, 1992
Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantationC V Paya, R H Wiesner, P E Hermans, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 20, 2002
Liver allograft iron accumulation in patients with and without pretransplantation hepatic hemosiderosisMonica B Parolin, Kenneth P Batts, Russell H Wiesner, et al.
Journal of Hypertension|August 31, 1999
Neural mechanisms in human obesity-related hypertensionM S Rumantir, M Vaz, G L Jennings, et al.
Mayo Clinic Proceedings|February 1, 1989
Evaluation of preoperative hematology-coagulation screening in liver transplantationD M Ritter, C A Owen, E J Bowie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantationsR C Walker, C V Paya, W F Marshall, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantationW R Kim, J J Poterucha, R A Jorgensen, et al.
The New England Journal of Medicine|June 29, 1989
Efficacy of liver transplantation in patients with primary biliary cirrhosisB H Markus, E R Dickson, P M Grambsch, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2014
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trialS K Asrani, R H Wiesner, J F Trotter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 11, 2000
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic studyR B Guerrero, K P Batts, L J Burgart, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueW J Sandborn, G M Lawson, T J Cody, et al.
Pageof 44